AquaBounty Technologies, Inc. (AQB) AI Stock Analysis
AQB AI stock analysis summary
AI ResearchAquaBounty Technologies, Inc. is a biotechnology company focused on commercial aquaculture, including its bioengineered AquAdvantage Salmon. For the trailing twelve months, the company recorded revenue of -$47,812 and an EPS of -$0.31. AquaBounty has a market capitalization of $5.7M and held $1.9M in cash and short-term investments as of June 30, 2026.
- Market cap
- $5.7M
- Revenue (TTM)
- -$47,812
- P/E
- —
- 1Y return
- -38.7% S&P 500 16.8%
- Avg. target
- $1.00 -9.9% vs last close
Bull case
- AquaBounty's closing price of $1.11 sits 10.7% above its 200-day moving average, supported by a year-to-date return of 19.4%.
- The balance sheet maintains short-term liquidity with a current ratio of 4.26 as of June 30, 2026.
- The company generated a 5-year revenue compound annual growth rate of 96.5% between FY2018 and FY2023.
Bear case
- Trailing twelve-month revenue fell to -$47,812 following a quarterly revenue drop of 93.5% year-over-year for the period ended June 30, 2026.
- Annual free cash flow remained deeply negative at -$93.1M in FY2023 alongside an operating cash flow of -$24.2M.
- The company's shares fell 98.6% over the past five years while its share count expanded by 44.9%.
What AquaBounty Technologies does
AquaBounty Technologies, Inc. is a biotechnology firm dedicated to advancing productivity within commercial aquaculture across the United States and Canada. The company specializes in genetic, genomic, and research activities focused on optimizing fish health and nutrition. Its central innovation is the development of AquAdvantage Salmon, a bioengineered Atlantic salmon designed for human consumption. In addition, it markets conventional Atlantic salmon, salmon eggs, fry, and related byproducts. Founded in 1991 and headquartered in Maynard, Massachusetts, the company combines genetic research with sustainable farming practices to address global seafood production challenges.
Growth and profitability
Between FY2019 and FY2023, AquaBounty's annual revenue rose from $186,738 in FY2019 to a peak of $3.1M in FY2022, before falling 21.2% to $2.5M in FY2023. Gross margins remained negative across the period, reporting -1813.8% in FY2019, -334.5% in FY2022, and -617.9% in FY2023. Annual net income was -$13.2M in FY2019 and -$27.6M in FY2023, resulting in an FY2023 EPS of -$7.39. R&D expenses decreased from $2.4M in FY2019 to $506,243 in FY2023. In the latest quarter ended June 30, 2026, revenue declined 93.5% year-over-year, contributing to a trailing twelve-month revenue of -$47,812.
Balance sheet and cash flow
As of June 30, 2026, AquaBounty Technologies held $1.9M in cash and short-term investments, with total assets of $11.7M and shareholders' equity of $2.8M. The company reported a current ratio of 4.26. Operating cash flow was -$24.2M in FY2023, while free cash flow stood at -$93.1M. Capital expenditures were $4 in FY2025. Over the trailing five years, the company's share count increased by 44.9%.
Valuation and performance
AquaBounty trades at a price-to-sales ratio of 2.5x and an enterprise value to revenue multiple of 7.7x, compared to a median price-to-sales ratio of 0.7x for its US-listed Consumer Defensive peers. Its price-to-book ratio is 1.9x, and its EV to EBITDA is 0.0x against the peer median of 11.7x. Over the past year, AQB shares fell 38.7%, while the S&P 500 (SPY) returned 16.8%. Over five years, the stock dropped 98.6%, compared to an 83.0% gain for the S&P 500.
What analysts expect
Analysts have a mean price target of $1.00 for AquaBounty Technologies, which sits 9.9% below its last close of $1.11 on October 16, 2026. The company has exceeded EPS consensus estimates in 1 of the last 4 quarters. AquaBounty's next earnings report is scheduled for October 27, 2026.
Key risks and what to watch
- Cash and short-term investments totaled $1.9M as of June 30, 2026, compared to historical annual operating cash burn of -$24.2M in FY2023.
- Trailing twelve-month return on equity was -50.2% and return on assets was -10.0%, reflecting ongoing operational losses.
- Institutional ownership is relatively low at 9.4%, while short interest stands at 3.6% of the float.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this AQB AI stock analysis
This page is an AI-written research summary of AquaBounty Technologies, Inc. (AQB). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: AQB income statement, AQB balance sheet, AQB key metrics, AQB chart. See the AQB stock overview for the latest quote and news.
AQB AI stock analysis FAQ
What is AquaBounty's ticker and market capitalization?
AquaBounty Technologies trades on the NASDAQ under the ticker AQB and has a market capitalization of $5.7M as of October 16, 2026.
Does AquaBounty pay a dividend?
AquaBounty Technologies does not pay a dividend.
What was AquaBounty's revenue and net income in FY2023?
In FY2023, AquaBounty generated $2.5M in revenue and reported net income of -$27.6M, which equaled an EPS of -$7.39.
What is the consensus analyst target for AQB stock?
The mean analyst price target is $1.00, which is 9.9% below the last closing price of $1.11 on October 16, 2026.